Table:
begin	end	state
1	20	cytoplasmic
21	41	transmembrane
42	47	non-cytoplasmic
48	70	transmembrane
71	91	cytoplasmic
92	114	transmembrane
115	126	non-cytoplasmic
127	145	transmembrane
146	154	cytoplasmic
155	176	transmembrane
177	195	non-cytoplasmic
196	215	transmembrane
216	235	cytoplasmic
236	255	transmembrane
256	288	non-cytoplasmic
289	312	transmembrane
313	332	cytoplasmic
333	353	transmembrane
354	361	non-cytoplasmic
362	383	transmembrane
384	394	cytoplasmic
395	413	transmembrane
414	418	non-cytoplasmic
419	437	transmembrane
438	449	cytoplasmic

Input:
>Pf1N1B4_5855 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_5855
MEIEEFGYKQELKRSLSLTDLVVYGMIFMIPIAPFGVYGYVNAEAPGMVPLAYIIGMVAM
LFTALSYGSMARAFPIAGSVYSYAQRGLNPHVGFIAGWLMLLDYLLIPPLLYVYAAMALN
HLYPDIPKVGFILAFLVSATFVNLRGITFTARMNIVFLLAQLVVLGIFLFYAWNALHSGG
GNGQLTLAPLYNPETFNFALLMQAVSIAVLSFLGFDAISTLAEEIKGDPGRSVGKAALIT
LLVMGVIFVVQTWIATDLAAGLGFKSADTAFYEIAEIAAGSWLATLTAVATALAWGVAVA
ITSQAAVSRLLFGMARDGKLPKVLAKVHPKHNTPYLSIYLVAVLSLVICYLFINSVDTLT
SLVNFGALSGFMLLHLTVINYYWRRQKSGQVIRHLICPVIGFIIVAAIMYNMGVDAQKLG
LIWIALGLVYLFFLNKLGASTALPDPSNG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server